The line item for FY 2016 CDC prostate cancer funding of $13,205,000 is restored in both the House and Senate appropriations bills, as authored by their committees.  Thanks to the several thousand of you who responded to Malecare’s call to action and wrote emails and letters to the Congressional House and Senate Budget Committee.  Since both the House and Senate committee bills restore funding, as best as we understand, there will be no conference discussion, nor is it likely to be debated by the full House or Senate.  Only a new amendment by the full committee could alter this outcome, and that seems unlikely.
Thank you for responding to our call to action at .  It is rare when so many prostate cancer survivors work together to create a force….we are all honored.